AZN logo

AstraZeneca PLC (AZN) Revenue

Annual revenue:

$54.10B+$8.28B(+18.08%)
December 31, 2024

Summary

  • As of today (August 18, 2025), AZN annual revenue is $54.10 billion, with the most recent change of +$8.28 billion (+18.08%) on December 31, 2024.
  • During the last 3 years, AZN annual revenue has risen by +$16.26 billion (+42.99%).
  • AZN annual revenue is now at all-time high.

Performance

AZN Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

Quarterly revenue:

$14.63B+$1.04B(+7.65%)
June 30, 2025

Summary

  • As of today (August 18, 2025), AZN quarterly revenue is $14.63 billion, with the most recent change of +$1.04 billion (+7.65%) on June 30, 2025.
  • Over the past year, AZN quarterly revenue has increased by +$1.69 billion (+13.06%).
  • AZN quarterly revenue is now -0.85% below its all-time high of $14.75 billion, reached on December 31, 2024.

Performance

AZN Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

TTM revenue:

$56.53B+$1.69B(+3.08%)
June 30, 2025

Summary

  • As of today (August 18, 2025), AZN TTM revenue is $56.53 billion, with the most recent change of +$1.69 billion (+3.08%) on June 30, 2025.
  • Over the past year, AZN TTM revenue has increased by +$7.40 billion (+15.06%).
  • AZN TTM revenue is now at all-time high.

Performance

AZN TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

AZN Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+18.1%+13.1%+15.1%
3 y3 years+43.0%+35.8%+28.1%
5 y5 years+121.8%+131.2%+111.4%

AZN Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+43.0%-0.8%+35.8%at high+29.0%
5 y5-yearat high+121.8%-0.8%+131.2%at high+111.4%
alltimeall timeat high+711.5%-0.8%+853.8%at high+3133.3%

AZN Revenue History

DateAnnualQuarterlyTTM
Jun 2025
-
$14.63B(+7.7%)
$56.53B(+3.1%)
Mar 2025
-
$13.59B(-7.9%)
$54.84B(+1.7%)
Dec 2024
$54.10B(+18.1%)
$14.75B(+8.8%)
$53.93B(+5.3%)
Sep 2024
-
$13.56B(+4.8%)
$51.21B(+4.2%)
Jun 2024
-
$12.94B(+2.0%)
$49.13B(+3.2%)
Mar 2024
-
$12.68B(+5.4%)
$47.61B(+3.9%)
Dec 2023
$45.81B(+3.3%)
$12.02B(+4.6%)
$45.81B(+1.8%)
Sep 2023
-
$11.49B(+0.7%)
$44.99B(+1.1%)
Jun 2023
-
$11.42B(+4.9%)
$44.48B(+1.5%)
Mar 2023
-
$10.88B(-2.9%)
$43.84B(-1.2%)
Dec 2022
$44.35B(+17.2%)
$11.21B(+2.0%)
$44.35B(-2.0%)
Sep 2022
-
$10.98B(+2.0%)
$45.26B(+2.5%)
Jun 2022
-
$10.77B(-5.4%)
$44.15B(+6.1%)
Mar 2022
-
$11.39B(-6.0%)
$41.59B(+7.7%)
Dec 2021
$37.83B(+37.1%)
$12.12B(+22.8%)
$38.61B(+12.2%)
Sep 2021
-
$9.87B(+20.0%)
$34.41B(+10.0%)
Jun 2021
-
$8.22B(-2.2%)
$31.29B(+6.4%)
Mar 2021
-
$8.40B(+6.1%)
$29.40B(+6.1%)
Dec 2020
$27.59B(+13.2%)
$7.92B(+17.4%)
$27.70B(+3.2%)
Sep 2020
-
$6.75B(+6.7%)
$26.84B(+0.4%)
Jun 2020
-
$6.33B(-5.6%)
$26.74B(+1.9%)
Mar 2020
-
$6.70B(-5.0%)
$26.23B(+2.7%)
Dec 2019
$24.38B(+10.4%)
$7.06B(+6.2%)
$25.54B(-0.7%)
Sep 2019
-
$6.65B(+14.2%)
$25.73B(+3.7%)
Jun 2019
-
$5.82B(-3.0%)
$24.80B(+0.6%)
Mar 2019
-
$6.01B(-17.1%)
$24.66B(+3.5%)
Dec 2018
$22.09B(-1.7%)
$7.25B(+26.6%)
$23.83B(+6.6%)
Sep 2018
-
$5.72B(+0.7%)
$22.36B(-2.2%)
Jun 2018
-
$5.68B(+9.7%)
$22.87B(+2.8%)
Mar 2018
-
$5.18B(-10.4%)
$22.24B(-1.0%)
Dec 2017
$22.46B(-2.3%)
$5.78B(-7.3%)
$22.46B(+0.9%)
Sep 2017
-
$6.23B(+23.4%)
$22.27B(+2.5%)
Jun 2017
-
$5.05B(-6.5%)
$21.74B(-2.5%)
Mar 2017
-
$5.41B(-3.2%)
$22.29B(-3.1%)
Dec 2016
$23.00B(-6.9%)
$5.58B(-2.0%)
$23.00B(-3.4%)
Sep 2016
-
$5.70B(+1.7%)
$23.82B(-1.0%)
Jun 2016
-
$5.60B(-8.4%)
$24.06B(-2.8%)
Mar 2016
-
$6.12B(-4.4%)
$24.77B(+0.2%)
Dec 2015
$24.71B(-6.9%)
$6.40B(+7.6%)
$24.71B(-1.3%)
Sep 2015
-
$5.95B(-5.7%)
$25.02B(-2.6%)
Jun 2015
-
$6.31B(+4.1%)
$25.69B(-1.7%)
Mar 2015
-
$6.06B(-9.8%)
$26.14B(-1.5%)
Dec 2014
$26.55B(+3.8%)
$6.72B(+1.6%)
$26.55B(-1.3%)
Sep 2014
-
$6.61B(-2.3%)
$26.88B(+1.6%)
Jun 2014
-
$6.76B(+4.7%)
$26.46B(+2.6%)
Mar 2014
-
$6.46B(-8.4%)
$25.80B(+0.8%)
Dec 2013
$25.59B(-8.2%)
$7.05B(+14.0%)
$25.60B(-1.2%)
Sep 2013
-
$6.19B(+1.4%)
$25.91B(-1.8%)
Jun 2013
-
$6.10B(-2.6%)
$26.38B(-2.0%)
Mar 2013
-
$6.26B(-14.9%)
$26.91B(-3.3%)
Dec 2012
$27.88B(-16.9%)
$7.36B(+10.4%)
$27.84B(-3.9%)
Sep 2012
-
$6.66B(+0.5%)
$28.96B(-5.2%)
Jun 2012
-
$6.63B(-7.8%)
$30.55B(-6.2%)
Mar 2012
-
$7.19B(-15.1%)
$32.56B(-4.0%)
Dec 2011
$33.54B(+0.7%)
$8.47B(+2.7%)
$33.92B(-1.0%)
Sep 2011
-
$8.25B(-4.6%)
$34.27B(+1.2%)
Jun 2011
-
$8.64B(+1.1%)
$33.88B(+2.8%)
Mar 2011
-
$8.55B(-3.1%)
$32.97B(+0.6%)
Dec 2010
$33.31B(+2.2%)
$8.83B(+12.3%)
$32.77B(-1.4%)
Sep 2010
-
$7.86B(+1.6%)
$33.25B(-1.0%)
Jun 2010
-
$7.73B(-7.4%)
$33.60B(-0.2%)
Mar 2010
-
$8.36B(-10.2%)
$33.65B(+2.0%)
Dec 2009
$32.61B(+2.3%)
$9.31B(+13.5%)
$32.99B(+7.6%)
Sep 2009
-
$8.20B(+5.2%)
$30.65B(+2.5%)
Jun 2009
-
$7.79B(+1.3%)
$29.91B(-0.4%)
Mar 2009
-
$7.69B(+10.4%)
$30.02B(+0.1%)
DateAnnualQuarterlyTTM
Dec 2008
$31.88B(+7.8%)
$6.97B(-6.7%)
$29.98B(-3.9%)
Sep 2008
-
$7.46B(-5.5%)
$31.18B(+1.0%)
Jun 2008
-
$7.90B(+3.3%)
$30.87B(+2.1%)
Mar 2008
-
$7.65B(-6.4%)
$30.24B(+2.3%)
Dec 2007
$29.56B(+11.6%)
$8.17B(+14.3%)
$29.56B(+3.6%)
Sep 2007
-
$7.15B(-1.7%)
$28.54B(+2.3%)
Jun 2007
-
$7.27B(+4.4%)
$27.91B(+2.6%)
Mar 2007
-
$6.97B(-2.6%)
$27.19B(+3.1%)
Dec 2006
$26.48B(+10.5%)
$7.15B(+9.8%)
$26.39B(+3.4%)
Sep 2006
-
$6.52B(-0.6%)
$25.52B(+3.8%)
Jun 2006
-
$6.56B(+6.5%)
$24.58B(+1.8%)
Mar 2006
-
$6.16B(-2.0%)
$24.14B(+1.3%)
Dec 2005
$23.95B(+11.8%)
$6.29B(+12.6%)
$23.84B(+2.1%)
Sep 2005
-
$5.58B(-8.7%)
$23.36B(+1.1%)
Jun 2005
-
$6.11B(+4.3%)
$23.09B(+3.0%)
Mar 2005
-
$5.86B(+1.1%)
$22.43B(+1.8%)
Dec 2004
$21.43B(+13.7%)
$5.80B(+9.0%)
$22.03B(+4.4%)
Sep 2004
-
$5.32B(-2.5%)
$21.11B(+2.4%)
Jun 2004
-
$5.45B(-0.2%)
$20.61B(+4.8%)
Mar 2004
-
$5.46B(+12.1%)
$19.66B(+3.1%)
Dec 2003
$18.85B(+5.6%)
$4.88B(+1.2%)
$19.08B(-0.1%)
Sep 2003
-
$4.81B(+6.8%)
$19.11B(+1.3%)
Jun 2003
-
$4.51B(-7.6%)
$18.86B(+0.5%)
Mar 2003
-
$4.88B(-0.4%)
$18.77B(+2.5%)
Dec 2002
$17.84B(+8.3%)
$4.90B(+7.4%)
$18.31B(+2.6%)
Sep 2002
-
$4.57B(+3.3%)
$17.85B(+3.7%)
Jun 2002
-
$4.42B(-0.0%)
$17.22B(+2.4%)
Mar 2002
-
$4.42B(-0.4%)
$16.82B(+2.9%)
Dec 2001
$16.48B(+4.3%)
$4.44B(+12.8%)
$16.34B(+17.8%)
Sep 2001
-
$3.93B(-2.1%)
$13.87B(-1.1%)
Jun 2001
-
$4.02B(+1.8%)
$14.02B(-9.2%)
Mar 2001
-
$3.95B(+100.8%)
$15.44B(+0.4%)
Dec 2000
$15.80B(+44.3%)
$1.97B(-51.9%)
$15.37B(+1.0%)
Sep 2000
-
$4.09B(-24.8%)
$15.22B(-1.3%)
Jun 2000
-
$5.44B(+40.0%)
$15.41B(+6.3%)
Mar 2000
-
$3.88B(+114.3%)
$14.50B(-4.2%)
Dec 1999
$10.95B(+19.9%)
$1.81B(-57.7%)
$15.13B(-12.9%)
Sep 1999
-
$4.28B(-5.4%)
$17.38B(+12.6%)
Jun 1999
-
$4.52B(0.0%)
$15.43B(+9.4%)
Mar 1999
-
$4.52B(+11.4%)
$14.10B(+17.5%)
Dec 1998
$9.13B(+7.4%)
$4.06B(+74.2%)
$12.00B(+17.3%)
Sep 1998
-
$2.33B(-27.0%)
$10.23B(+2.3%)
Jun 1998
-
$3.19B(+32.0%)
$10.00B(+10.0%)
Mar 1998
-
$2.42B(+5.7%)
$9.09B(+1.5%)
Dec 1997
$8.51B(+1.7%)
$2.29B(+9.0%)
$8.96B(-20.2%)
Sep 1997
-
$2.10B(-8.1%)
$11.22B(-1.9%)
Jun 1997
-
$2.28B(0.0%)
$11.44B(+0.0%)
Mar 1997
-
$2.28B(-49.9%)
$11.43B(+0.0%)
Dec 1996
$8.37B(+8.2%)
$4.56B(+97.0%)
$11.43B(+32.4%)
Sep 1996
-
$2.31B(+1.5%)
$8.63B(+4.6%)
Jun 1996
-
$2.28B(0.0%)
$8.26B(+3.3%)
Mar 1996
-
$2.28B(+29.2%)
$7.99B(+3.4%)
Dec 1995
$7.73B(+12.7%)
$1.76B(-8.9%)
$7.73B(-0.8%)
Sep 1995
-
$1.94B(-4.1%)
$7.80B(+2.4%)
Jun 1995
-
$2.02B(-0.0%)
$7.61B(+2.4%)
Mar 1995
-
$2.02B(+10.4%)
$7.43B(+2.5%)
Dec 1994
$6.86B(+2.9%)
$1.83B(+4.2%)
$7.25B(+4.2%)
Sep 1994
-
$1.75B(-4.6%)
$6.96B(+3.2%)
Jun 1994
-
$1.84B(0.0%)
$6.74B(+1.3%)
Mar 1994
-
$1.84B(+19.8%)
$6.66B(+1.3%)
Dec 1993
$6.67B(-4.6%)
$1.53B(-0.2%)
$6.57B(+30.5%)
Sep 1993
-
$1.54B(-12.1%)
$5.03B(+44.0%)
Jun 1993
-
$1.75B(0.0%)
$3.50B(+100.0%)
Mar 1993
-
$1.75B
$1.75B
Dec 1992
$6.98B(+0.8%)
-
-
Dec 1991
$6.93B(+2.4%)
-
-
Dec 1990
$6.77B
-
-

FAQ

  • What is AstraZeneca PLC annual revenue?
  • What is the all time high annual revenue for AstraZeneca PLC?
  • What is AstraZeneca PLC annual revenue year-on-year change?
  • What is AstraZeneca PLC quarterly revenue?
  • What is the all time high quarterly revenue for AstraZeneca PLC?
  • What is AstraZeneca PLC quarterly revenue year-on-year change?
  • What is AstraZeneca PLC TTM revenue?
  • What is the all time high TTM revenue for AstraZeneca PLC?
  • What is AstraZeneca PLC TTM revenue year-on-year change?

What is AstraZeneca PLC annual revenue?

The current annual revenue of AZN is $54.10B

What is the all time high annual revenue for AstraZeneca PLC?

AstraZeneca PLC all-time high annual revenue is $54.10B

What is AstraZeneca PLC annual revenue year-on-year change?

Over the past year, AZN annual revenue has changed by +$8.28B (+18.08%)

What is AstraZeneca PLC quarterly revenue?

The current quarterly revenue of AZN is $14.63B

What is the all time high quarterly revenue for AstraZeneca PLC?

AstraZeneca PLC all-time high quarterly revenue is $14.75B

What is AstraZeneca PLC quarterly revenue year-on-year change?

Over the past year, AZN quarterly revenue has changed by +$1.69B (+13.06%)

What is AstraZeneca PLC TTM revenue?

The current TTM revenue of AZN is $56.53B

What is the all time high TTM revenue for AstraZeneca PLC?

AstraZeneca PLC all-time high TTM revenue is $56.53B

What is AstraZeneca PLC TTM revenue year-on-year change?

Over the past year, AZN TTM revenue has changed by +$7.40B (+15.06%)
On this page